Renowned investor Stanley Druckenmiller achieved 30% average annual returns at Duquesne from 1981 to 2010. Natera’s revenue increased by 35% year-over-year in Q3 2025, surpassing analyst estimates by 14%. Insmed’s stock soared from below $26 in May 2024 to almost $200 with a 52% revenue growth in Q3 2025. Druckenmiller is now investing in Natera, Insmed, and Teva Pharmaceuticals. He has a successful record in global macro investing and is known for his high returns.
Stanley Druckenmiller began his financial career as an oil analyst in 1977. By 1981, he founded his investment firm, Duquesne Capital Management, where he achieved impressive returns. Druckenmiller’s reputation grew as he managed Duquesne while consulting for the Dreyfus Corporation and later became the lead portfolio manager for the Quantum Fund.
Natera specializes in genetic testing using cell-free DNA, with its stock surging over 500% since late 2023. Revenue rose 34.66% year-over-year in Q3 2025, surpassing analyst expectations. Druckenmiller has been accumulating Natera stock since Q3 2022 and now holds a significant position.
Insmed, a biopharmaceutical company, focuses on developing therapies for rare diseases, with a significant increase in revenue in Q3 2025. Druckenmiller began buying Insmed stock in Q2 2020 and has steadily increased his stake, with the stock surging from below $26 to nearly $200.
Teva Pharmaceuticals, the world’s largest generic drug manufacturer, has seen a recovery in its stock since September 2023. Druckenmiller has recently started accumulating Teva stock and expects a full recovery. His record in investing in pharmaceutical companies has been exceptional, with Teva now constituting a significant portion of his portfolio.
Many Americans are rethinking retirement after realizing they can retire earlier than expected by understanding the difference between accumulation and distribution of wealth. By answering three quick questions, individuals are reassessing their retirement plans. Take 5 minutes to learn more about this retirement income strategy.
Read more at Yahoo Finance: This Investor Beat the Market for 3 Decades Without a Single Losing Year. 3 Stocks He’s Buying Now.